Woluwe Saint-Lambert, Belgium

Martin Bernard Catherine Bousmanne


Average Co-Inventor Count = 8.1

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Woluwe Saint-Lambert, BE (2022 - 2023)
  • Woluwe Saint-Labmert, BE (2024)

Company Filing History:


Years Active: 2022-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Martin Bernard Catherine Bousmanne: Innovator in Pharmaceutical Compositions

Introduction

Martin Bernard Catherine Bousmanne is a notable inventor based in Woluwe Saint-Lambert, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating neurodegenerative and neurodevelopmental disorders. With a total of four patents to his name, Bousmanne's work is recognized for its innovative approach to drug formulation.

Latest Patents

Bousmanne's latest patents focus on compositions of trofinetide. These disclosures describe compounds of Formula (I), including stereoisomers and side compounds. The patents detail pharmaceutical compositions and methods for manufacturing these compounds using silylation reagents. More specifically, they outline the manufacture of trofinetide and its side products, as well as the compositions and products containing these compounds for pharmaceutical uses.

Career Highlights

Throughout his career, Bousmanne has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Neuren Pharmaceuticals Limited and Acadia Pharmaceuticals Inc. His expertise in the field has allowed him to contribute to the advancement of therapeutic solutions for complex medical conditions.

Collaborations

Bousmanne has collaborated with several professionals in his field, including Cecilia Betti and Clive Blower. These partnerships have further enhanced his research and development efforts, leading to innovative solutions in pharmaceutical compositions.

Conclusion

Martin Bernard Catherine Bousmanne is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of neurodegenerative and neurodevelopmental disorders. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…